Han A C, Soler A P, Tang C K, Knudsen K A, Salazar H
Department of Pathology, The Reading Hospital and Medical Center, Reading, PA 19612, USA.
Arch Pathol Lab Med. 2000 Aug;124(8):1147-51. doi: 10.5858/2000-124-1147-NLOECE.
Cadherins are cell-cell adhesion proteins that act as tumor suppressor genes and have a critical role in cell sorting and tissue formation during organogenesis. The pattern of cadherin expression constitutes a useful diagnostic and prognostic tool in the evaluation of tumors and for determining the histogenesis of tumor cells. We have previously characterized the cell types of several tumors based on the expression of individual cadherins.
To investigate the expression of cadherins in Merkel cell carcinomas.
Paraffin immunohistochemical analysis of the 3 best-studied cadherins was performed on 35 cases of Merkel cell carcinoma.
E-cadherin was expressed in 34 (97%) of 35 Merkel cell carcinomas examined, N-cadherin was expressed in 22 (63%) of 35 cases, and P-cadherin was expressed in 15 (43%) of 35 cases. This frequency of cadherin expression was similar to a group of small cell and neuroendocrine tumors from other primary sites. Interestingly, the localization of E-cadherin expression was unique in Merkel cell carcinomas compared with other primary neuroendocrine tumors. Merkel cell carcinomas showed marked preference for nuclear versus membrane localization, whereas small cell tumors from other sites showed fewer cases of nuclear E-cadherin expression. The nuclear localization of E-cadherin did not correlate with cadherin-associated protein beta-catenin nuclear expression.
Our findings show that E-cadherin is the most frequently expressed cadherin in Merkel cell carcinoma, followed in frequency by N-cadherin then P-cadherin. The pattern of nuclear E-cadherin expression is more frequent for Merkel cell carcinoma than small cell tumors of other primary sites. These observations suggest that E-cadherin expression and function are altered in Merkel cell carcinoma, and this finding has potential use in the differential diagnosis of these tumors.
钙黏蛋白是细胞间黏附蛋白,起肿瘤抑制基因的作用,在器官发生过程中的细胞分选和组织形成中起关键作用。钙黏蛋白的表达模式在肿瘤评估以及确定肿瘤细胞的组织发生方面是一种有用的诊断和预后工具。我们之前已根据单个钙黏蛋白的表达对几种肿瘤的细胞类型进行了特征描述。
研究钙黏蛋白在默克尔细胞癌中的表达情况。
对35例默克尔细胞癌进行石蜡免疫组织化学分析,检测3种研究最多的钙黏蛋白。
在检测的35例默克尔细胞癌中,34例(97%)表达E-钙黏蛋白,22例(63%)表达N-钙黏蛋白,15例(43%)表达P-钙黏蛋白。这种钙黏蛋白的表达频率与一组来自其他原发部位的小细胞和神经内分泌肿瘤相似。有趣的是,与其他原发性神经内分泌肿瘤相比,默克尔细胞癌中E-钙黏蛋白表达的定位具有独特性。默克尔细胞癌明显更倾向于核定位而非膜定位,而来自其他部位的小细胞肿瘤中E-钙黏蛋白核表达的病例较少。E-钙黏蛋白的核定位与钙黏蛋白相关蛋白β-连环蛋白的核表达无关。
我们的研究结果表明,E-钙黏蛋白是默克尔细胞癌中表达最频繁的钙黏蛋白,其次是N-钙黏蛋白,然后是P-钙黏蛋白。默克尔细胞癌中E-钙黏蛋白核表达模式比其他原发部位的小细胞肿瘤更常见。这些观察结果表明,默克尔细胞癌中E-钙黏蛋白的表达和功能发生了改变,这一发现可能有助于这些肿瘤的鉴别诊断。